You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Familial Hemophagocytic Lymphohistiocytosis in the Neonate

Whaley, Brian F. MSN, RN-C, NNP-BC

Section Editor(s): King, Cheryl

Advances in Neonatal Care:
doi: 10.1097/ANC.0b013e318210d02c
Case of the Month
Abstract

Familial hemophagocytic lymphohistiocytosis is a rare and inherited disease that affects both males and females equally and is most often fatal if not treated. Diagnosis is challenging because it mimics severe sepsis by demonstrating hepatomegaly, splenomegaly, persistent fever, central nervous system involvement, and cytopenias. The etiologies of hemophagocytic lymphohistiocytosis have been well established through the identification of 3 causative genetic mutations. Therapies for hemophagocytic lymphohistiocytosis focus on restoring health by diminishing the disease sequelae with a goal of hematopoietic stem cell transplant, the only known curative therapy for hemophagocytic lymphohistiocytosis. Current research is being conducted to identify other causative genetic mutations and newer, more effective treatment modalities.

Author Information

School of Medicine, University of North Carolina, Winston-Salem.

Correspondence: Brian F. Whaley, MSN, RN-C, NNP-BC, School of Medicine, University of North Carolina, 2031 Bethany Trace Ln, Winston-Salem, NC 27127 (bwhaley@med.unc.edu).

© 2011 National Association of Neonatal Nurses